In a significant advancement in areas of adult and geriatric care, Akums Drugs & Pharmaceuticals Ltd. has released India's first high-strength paracetamol oral suspension at 500mg/5ml, establishing a new model for the country's pharmaceutical...
In a significant step to enhance its natural health portfolio, SuanNutra Group's European distribution division Gonmisol has signed an exclusive distribution agreement with Indian-based K Patel Phyto Extractions...
Roche faced a regulatory setback today as the U.S. FDA issued a Complete Response Letter (CRL) for its bid to expand Columvi (glofitamab) in combination with gemcitabine and oxaliplatin (GemOx) for certain DLBCL patients...
India's burgeoning heart disease burden is not only seen in melodramatized reports of cardiac arrests of young heroes but also in a frightening 50% five-year jump in sales of cardiovascular medicines.
Sun Pharma announced that its monoclonal antibody drug ILUMYA (tildrakizumab 100 mg) has demonstrated favorable results in two Phase 3 clinical trials in active psoriatic arthritis
Top-line findings from two Phase 3 clinical trials assessing the safety and effectiveness of tildrakizumab 100 mg (ILUMYA) given over a 24-week period for the treatment of active psoriatic arthritis were released today by Sun Pharmaceutical
.png "India to Align Pharma Cleanroom Standards with WHO Guidelines")
India is going to change the microbial contamination limits as per Schedule M in the Drugs and Cosmetics Rules to the global WHO limits in a major initiative to improve pharmaceutical manufacturing standards. The decision was taken at the Drugs...
In a breakthrough for health care, Kozhikode has become the first district in Kerala to provide continuous glucose monitoring (CGM) systems free of charge to children diagnosed with Type 1 Diabetes (T1D)...
Indian Council of Medical Research (ICMR), along with Regional Medical Research Centre, Bhubaneswar (RMRCBB) and National Institute of Malaria Research (NIMR) is leading the formulation of a new indigenous malaria vaccine called AdFalciVax.
Torrent Pharmaceuticals has sought the Competition Commission of India (CCI) clearance for its planned ?19,500 crore acquisition of a majority holding in JB Chemicals & Pharmaceuticals.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")